✦ LIBER ✦

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis

✍ Scribed by Izquierdo, G. (author);O'Connor, P. (author);Montalban, X. (author);Von Rosenstiel, P. (author);Cremer, M. (author);De Vera, A. (author);Sfikas, N. (author);Francis, G. (author);Radue, E. W. (author);Kappos, Ludwig (author)

Book ID: 121844870
Publisher: SAGE Publications
Year: 2013
Tongue: English
Weight: 689 KB
Volume: 20
Category: Article
ISSN: 1352-4585
DOI: 10.1177/1352458513513059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-year results from a phase 2 study o

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis

✍ Izquierdo, G. (author);O'Connor, P. (author);Montalban, X. (author);Von Rosensti 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 689 KB

Phase II study of oral fingolimod (FTY72

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

✍ Comi, G.; O'Connor, P.; Montalban, X.; Antel, J.; Radue, E-W.; Karlsson, G.; Poh 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 732 KB

Oral fingolimod (FTY720) in multiple scl

Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study

✍ O'Connor, P.; Comi, G.; Montalban, X.; Antel, J.; Radue, E. W.; de Vera, A.; Poh 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 507 KB

Fingolimod (FTY720) therapy in Japanese

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

✍ Kira, Jun-ichi; Itoyama, Yasuto; Kikuchi, Seiji; Hao, Qi; Kurosawa, Takayoshi; N 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 216 KB

Outcomes of switching directly to oral f

Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis

✍ Fox, Edward; Edwards, Keith; Burch, Gordon; Wynn, Daniel R.; LaGanke, Chris; Cra 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 729 KB

Effect of disease-modifying therapies on

Effect of disease-modifying therapies on brain volume in relapsing–remitting multiple sclerosis: Results of a five-year brain MRI study

✍ Omar Khan; Fen Bao; Megha Shah; Christina Caon; Alexandros Tselis; Ronald Bailey 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 418 KB